In order to bridge the great gaps, Chinese Stroke Association (CSA) and American Heart Association (AHA) sought to develop, conduct, and assess a multifaceted quality improvement intervention to increase the adherent rate of IV tPA and ET and improve 3-month clinical outcomes for these patients through our cluster-randomized stepped-wedge IMPROVE: Stroke in China trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
15,895
1. hospital tool kits for quality improvement of reperfusion therapy ; 2. organizational stakeholder and opinion leader meetings; 3. data monitoring and feedback reports; 4. webinar for hospital teams
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The adherence rate of guidelines for IV-tPA and/or endovascular treatment in eligible patients.
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
proportional change of intravenous thrombolytic therapy in eligible patients 4.5h after the onset
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
proportional change of endovascular treatment in eligible patients 6h after the onset
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
time from arrival to hospitals to intravenous thrombolytic therapy
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
door-to-puncture time
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
in-hospital mortality
Time frame: participants will be followed for the duration of hospital stay, an expected average of 2 weeks
3-month disability(mRS≥3 )
Time frame: patients will be followed up at 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.